Company Search:
Advanced Search
Sponsored Links
OTCPharm PAO Company Snapshot
OTCPharm PAO operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares OTCPharm PAO with three other pharmaceutical manufacturers in Europe: Vetoquinol Sa of France (2016 sales of 350.35 million Euro [US$430.41 million] of which 76% was Europe), Dechra Pharmaceuticals PLC of the United Kingdom (£247.56 million [US$346.73 million] of which 76% was European Pharmaceuticals), and Swedish Orphan Biovitrum AB (publ) which is based in Sweden (4.50 billion Swedish Kronor [US$532.37 million] of which 41% was Haemophilia: Elocta).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for OTCPharm PAO
  Stock Data: Recent Stock Performance:
  Current Price (3/20/2018): 19.95
(Figures in Russian Rubles)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
OTCPharm PAO Key Data:
  Ticker: OTCP Country: Russian Federation
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 26,760,604,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Russian Rubles Market Cap: 2,901,183,503
  Fiscal Yr Ends: December Shares Outstanding: 145,422,732
  Share Type: Ordinary Closely Held Shares: 133,658,033
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.